Top Markets
Coin of the day
Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.

SIGY
Classificação em ações #41133
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise... Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths. Furthermore, Sigyn Therapeutics is actively evaluating the potential of Sigyn Therapy to address a broad spectrum of other therapeutic targets, including bacterial endotoxins, peptidoglycan, and lipoteichoic acid; various viral pathogens; harmful hepatic toxins; CytoVesicles; and significant pro-inflammatory cytokines such as tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6. The company is headquartered in San Diego, California.
Preço da ação
$0.03
Última sincronização: 2026-08-12
Valor de mercado
$48.16K
Variação (1 dia)
-23.08%
Variação (1 ano)
-98.93%
País
US
Negociar Sigyn Therapeutics, Inc. (SIGY)

Categoria

EPS de Sigyn Therapeutics, Inc. (SIGY)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Sigyn Therapeutics, Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Sigyn Therapeutics, Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE